Netherlands ends OTC sale of Mylan's Inhibin

7 November 2018 - Deborah Wilkes

Archived

The Dutch Medicines Evaluation Board (MEB) has banned OTC sales of Mylan's Inhibin (hydroquinine hydrobromide) following concerns about cardiovascular safety.

Click tags below for more information on topics:

Mylan

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: